Over 30 lakh diabetes patients across the country were on pioglitazone drug banned last week City doctors are receiving anxious calls from diabetic patients worried about ban on anti-diabetic drug pioglitazone. “Pioglitazone is a good drug. The only issue is that it should be used with certain restrictions,” said Dr KP Singh, senior consultant, endocrinology, Fortis Hospital, SAS Nagar. He said, “It is an affordable drug, which is at least 10 times cheaper as compared to other medicines. So we were prescribing it commonly.” Following the ban, now Dr Singh is getting 30-40 queries every day from his patients regarding the medicine. The medicine, Dr Singh said, should not be used for patients suffering from urinary bladder cancer, heart problems, kidney failure. “The patients can now either switch to insulin or opt for costlier yet less effective drugs,” Dr Singh said. According to experts, Pioglitazone is the second and third line of treatment for Type 2 diabetes. According to data available, over 30-lakh diabetes patients across the country were on pioglitazone drug banned last week. The union health ministry had issued a notification announcing the ban on June 18. Along with pioglitazone, two other drugs – analgin (painkiller) and deanxit (anti-depressant) – were also banned due to alleged health risks associated with the drugs. Doctors complained that the Indian government relied on foreign data which links urinary bladder cancer with the intake of pioglitazone. Some doctors allege that scientific evidence was ignored before banning the drug and that its benefits outweigh the risk factors. However, Dr RJ Dash, considered a pioneer in endocrinology in the country, believes that it was a right decision to ban the medicine. “When it is established that there are serious side effects of the medicine then there is no question of continuing the sale of medicine,” he said. He added that some physicians were using this medicine mindlessly without knowing its side effects, so it was right to stop the sale of this medicine. Ref: HT live Chandigarh- Tuesday, July 9,2013

Chereso in News

Team FENFURO participated in VIBRANT GUJARAT GLOBAL TRADE SHOW – 2015 held at The Exhibition Centre, Near Mahatma Mandir, Gandhinagar, Gujarat during 7th to 13th January, 2015. Free catalogues/informative material were distributed among visitors for awareness of Diabetes and its complications, Obesity & General Health.

After ban on diabetes drug, docs flooded with queries

Chereso in News

Over 30 lakh diabetes patients across the country were on pioglitazone drug banned last week City doctors are receiving anxious calls from diabetic patients worried about ban on anti-diabetic drug pioglitazone. “Pioglitazone is a good drug. The only issue is that it should be used with certain restrictions,” said Dr KP Singh, senior consultant, endocrinology,…

Diabetes is a progressive disease; therefore, a single treatment regimen cannot be followed for long. Also it is a complex disease with genetic predisposition; hence, a single therapeutic regimen is not applicable in all cases. The prevalence of diabetes has reached epidemic proportions, resulting in an enormous increase in the need for dialysis and coronary artery bypass grafts. Treatments are also needed for eye disease ,neuropathy, sexual dysfunction depression and leg ulcers. According to the international Diabetes Federation (IDF), in 2011, the number of persons suffering from diabetes in india was 61.3 million and is estimated to reach 101.2 million by 2030. Diabetes is a complex metabolic disorder, with a multitude of components, one of which is the elevation or excursion in blood sugar .The complexity of the disease urgently requires technological interventions to be a part of day to day management in the absence of which the therapy fails, as is happening with more than 80 % of patients on conventional diabetes treatment. After the publication of the Diabetes Control and Complications Trial (DCCT) with type 1 diabetes , and the United Kingdom Prospective Diabetes Study (UKPDS) with type 2 diabetes, the management of diabetes has radically changed in the past decade. Now, self –monitoring of blood glucose (SMBG) with a glucometer , has become indispensable, whatever may be the type and stage of the illness. Technology in diabetes is linked to blood glucose monitoring and delivery devices. Blood Glucose monitors and insulin pens have been popular for years. Continuous glucose monitoring (CGM) and insulin pump therapy are being incorporated gradually and systematically into routine diabetes therapy. The idea behind incorporating technology in diabetes care is to ensure success in maintaining healthy levels of HbA1c,blood pressure and LDL cholesterol thereby , preventing the onset of micro and macro vascular complications of diabetes. Diabetes is a progressive disease therefore a single treatment regimen cannot be followed for long Also, it is a complex disease with genetic predisposition hence , a single therapeutic regimen is not applicable in all cases.CGM replaces the pricking of a finger tip to get a drop of blood , which is used ia a glucometer to measure the blood glucose with a stand alone tiny sensor needle with measures up to 288 blood glucose values over a period of 24 hours and can be situ from three days to three weeks. This device can be used as a blindor a real time device where the patient will be able to see the change in the blood glucose trends, the lows the highs , the excursions, the trend during sleep etc, This is the first in a series of columns that will deal with technological innovations in diabetes. Source: DOC N DOC, February 2012 by Jothydev Kesavadev, MD

Chereso in News

TEAM FENFURO partcipated in Ninth Edition of PHD Chamber’s Annual International Trade Expo “Punjab International Trade Expo (PITEX) 2014 from 4-8 December’2014 at Amritsar, Punjab.The Government of Punjab was the ‘Host State’. Free catalogues/informative material were distributed among visitors for awareness of Diabetes and its complications, Obesity, PCOS(ploycystic ovarian syndrome) & General Health.

Technology In Diabetes

Chereso in News

Diabetes is a progressive disease; therefore, a single treatment regimen cannot be followed for long. Also it is a complex disease with genetic predisposition; hence, a single therapeutic regimen is not applicable in all cases. The prevalence of diabetes has reached epidemic proportions, resulting in an enormous increase in the need for dialysis and coronary…

TEAM FENFURO had participated in UPDACON-annual congress of Uttar Pradesh Diabetes Association which was held on 17 & 18 November 2012 at Scientific Convention Center, CSMMU ,Lucknow, the state capital of Uttar Pradesh which happens to be highest populated state of India. The conference was attended by more than 600 physicians and endocrinologists who put their idea to fight with Diabetes and create awareness among people for the prevention of diabetes and they have also promoted life style modifications as well as motivated people for early detection and treatment and to avoid late life threatening complications of Diabetes. It was the endeavor to update physicians and general practitioners about newer modalities of diagnosis and treatment.

Chereso in News

TEAM FENFURO participated in 6th World Ayurveda Congress & Arogya held at Pragati Maidan, New Delhi from 06th to 09thNovember 2014. Free catalogues/informative material were distributed among visitors for awareness of Diabetes and its complications, Obesity, PCOS(ploycystic ovarian syndrome) & General Health.

Diabetes Drug May Affect Thyroid in Some Patients

Chereso in News

Medicine tied to lower thyroid-stimulating hormone levels in those with underactive thyroid WebMD News from HealthDay , By Mary Elizabeth Dallas, HealthDay Reporter MONDAY, Sept. 22, 2014 (HealthDay News) –Metformin, a drug commonly used to treat diabetes, may raise the risk of low levels of thyroid-stimulating hormone (TSH) among patients with an under active thyroid,…